Form 4: Quest Diagnostics Executive Sam Samad Reports Stock Award and Tax Withholding
SEC Form 4 Filing
Executive Vice President & CFO of Quest Diagnostics, Sam Samad, reports acquisition of shares through a performance share award and disposition of shares to cover tax obligations.
Summary
- On March 4, 2025, Sam Samad, Executive Vice President & CFO of Quest Diagnostics, acquired 13,884 shares of common stock at a price of $173.74 per share as settlement of a performance share award.
- On the same day, Samad disposed of 7,684 shares of common stock at $173.74 per share to cover tax withholding obligations arising from the settlement of the performance stock award.
- Following these transactions, Samad beneficially owns 26,377 shares of Quest Diagnostics common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Positives
- The acquisition of shares through a performance share award suggests that the executive has met certain performance criteria, which could be viewed positively.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates activity related to executive compensation and tax obligations, which are common occurrences in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they primarily concern executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/04/2025 | Date of stock acquisition and disposition for tax withholding. |
| 03/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.